Immuron (IMRN) Times Interest Earned (2016 - 2024)
Immuron (IMRN) posted quarterly Times Interest Earned of -$631.4 million for Q4 2024, down 125243419.8% year-over-year from N/an in Q1 2024, and down 125243419.8% quarter-over-quarter from -$504.12 in Q4 2023.
Immuron (IMRN) Times Interest Earned (2016 - 2024) Analysis & Trends
Immuron's Times Interest Earned history runs 9 years deep, the most recent figure standing at -$631.4 million for Q4 2024.
- In Q4 2024, Times Interest Earned fell 125243419.8% year-over-year to -$631.4 million; the TTM figure through Dec 2024 stood at -$631.4 million (down 89396805.75% YoY), while the FY2025 annual figure was -$731.63, up 4.45% from the prior year.
- Times Interest Earned for Q4 2024 stood at -$631.4 million, down from -$504.12 in the prior quarter.
- The five-year high for Times Interest Earned was $216.73 in Q4 2021, with the low at -$631.4 million in Q4 2024.
- The 5-year median for Times Interest Earned is -$251.02 (2020), against an average of -$105.2 million.
- The sharpest annual moves came in 2021 and 2024: Times Interest Earned surged 10288.34% in 2021, then slumped 125243419.8% in 2024.
- Immuron's Times Interest Earned stood at $2.09 in 2020, then soared by 10288.34% to $216.73 in 2021, then slumped by 63.84% to $78.36 in 2022, then tumbled by 743.36% to -$504.12 in 2023, then plunged by 125243419.8% to -$631.4 million in 2024.
- Business Quant data shows IMRN's Times Interest Earned at -$631.4 million in Q4 2024, -$504.12 in Q4 2023, and -$1100.3 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -631.38 Mn |
| Dec 31, 2023 | -504.12 |
| Jun 30, 2023 | -1,100.27 |
| Dec 31, 2022 | 78.36 |
| Dec 31, 2021 | 216.73 |
| Dec 31, 2020 | 2.09 |
| Dec 31, 2019 | 0.74 |
| Dec 31, 2018 | 40,562.51 |
| Dec 31, 2017 | -1,306.58 |
| Dec 31, 2016 | 62.10 |
| Jun 30, 2016 | -16.97 |